Nevro Corp.
US ˙ NYSE ˙ US64157F1030
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

SecurityNVRO / Nevro Corp.
InstitutionJefferies Group LLC
Latest Disclosed Ownership156,412 shares
Latest Disclosed Value $ 7,288,799
Jefferies Group LLC ownership in NVRO / Nevro Corp.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 156,412 shares of Nevro Corp. (US:NVRO) valued at $7,288,799 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 150,000 shares of Nevro Corp.. This represents a change in shares of 4.27% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (NVRO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 150,000 of underlying shares valued at $6,990,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NVRO / Nevro Corp. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 NEVRO COM 64157F103 156,412 6,412 4.27 7,289 10.86 0.0610
2022-11-14 2022-09-30 13F NEVRO COM 64157F103 165,454 15,412 7,296 0.0581
2023-09-21 2022-06-30 13F/A-1 NEVRO COM 64157F103 150,000 11,322 8.16 6,574 -34.46 0.0546
2022-08-15 2022-06-30 13F NEVRO COM 64157F103 150,042 11,364 6,575 0.0513
2023-09-21 2022-03-31 13F/A-1 NEVRO COM 64157F103 138,678 70,481 103.35 10,031 81.44 0.0631
2022-05-16 2022-03-31 13F NEVRO COM 64157F103 138,884 70,687 10,033 0.0585
2023-09-21 2021-12-31 13F/A-1 NEVRO COM 64157F103 68,197 46,000 207.24 5,529 114.01 0.0324
2022-02-14 2021-12-31 13F NEVRO COM 64157F103 68,197 46,000 5,529 0.0297
2023-09-21 2021-09-30 13F/A-2 NEVRO COM 64157F103 22,197 11,864 114.82 2,583 50.79 0.0188
2021-12-17 2021-09-30 13F/A-1 NEVRO COM 64157F103 22,197 11,864 2,583 0.0178
2021-11-15 2021-09-30 13F NEVRO COM 64157F103 22,197 11,864 2,583 0.0167
2023-09-21 2021-06-30 13F/A-2 NEVRO COM 64157F103 10,333 161 1.58 1,713 20.80 0.0108
2021-08-20 2021-06-30 13F/A-1 NEVRO COM 64157F103 10,333 161 1,713 0.0101
2021-08-16 2021-06-30 13F NEVRO COM 64157F103 10,333 161 1,713 0.0101
2023-09-21 2021-03-31 13F/A-1 NEVRO COM 64157F103 10,172 10,172 1,419 0.0124
2021-05-14 2021-03-31 13F NEVRO COM 64157F103 10,172 10,172 1,419 0.0124
2023-09-21 2020-12-31 13F/A-1 NEVRO COM 64157F103 0 -24,565 -100.00 0 -100.00
2021-02-16 2020-12-31 13F NEVRO COM 64157F103 0 -24,565 0
2020-11-13 2020-09-30 13F NEVRO COM 64157F103 24,565 13,473 121.47 3,422 158.26 0.0379
2020-11-02 2020-06-30 13F/A-1 NEVRO COM 64157F103 11,092 -14,510 -56.68 1,325 -48.24 0.0156
2020-08-14 2020-06-30 13F NEVRO COM 64157F103 11,092 -14,510 1,325 17,805.1576
2020-05-15 2020-03-31 13F NEVRO COM 64157F103 25,602 25,602 2,560 0.0318
2020-02-13 2019-12-31 13F NEVRO COM 64157F103 0 -13,086 -100.00 0 -100.00
2019-11-13 2019-09-30 13F NEVRO COM 64157F103 13,086 6,031 85.49 1,125 146.17 0.0087
2019-08-14 2019-06-30 13F NEVRO COM 64157F103 7,055 5,948 537.31 457 562.32 0.0033
2019-05-15 2019-03-31 13F NEVRO COM 64157F103 1,107 1,107 69 0.0006
2018-08-14 2018-06-30 13F NEVRO COM 64157F103 0 -5,950 -100.00 0 -100.00
2018-05-15 2018-03-31 13F NEVRO COM 64157F103 5,950 -3,503 -37.06 516 -20.98 0.0028
2018-02-14 2017-12-31 13F NEVRO COM 64157F103 9,453 4,946 109.74 653 54.74 0.0031
2017-05-15 2017-03-31 13F NEVRO COM 64157F103 4,507 2,207 95.96 422 75.83 0.0031
2016-11-14 2016-09-30 13F NEVRO COM 64157F103 2,300 2,297 76,566.67 240 0.0012
2016-08-12 2016-06-30 13F NEVRO COM 64157F103 3 -173 -98.30 0 -100.00
2016-05-11 2016-03-31 13F NEVRO COM 64157F103 176 176 10 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-06-30 13F/A NEVRO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F NEVRO COM Call 0 0 n/a n/a n/a
2023-09-21 2022-03-31 13F/A NEVRO COM Call 6,200 -84.95 448 -86.59 n/a n/a n/a
2022-05-16 2022-03-31 13F NEVRO COM Call 6,200 448 n/a n/a n/a
2023-09-21 2021-12-31 13F/A NEVRO COM Call 41,200 3,340 n/a n/a n/a
2022-02-14 2021-12-31 13F NEVRO COM Call 41,200 3,340 n/a n/a n/a
2021-08-20 2021-06-30 13F/A NEVRO COM Call 0 0 n/a n/a n/a
2023-09-21 2021-06-30 13F/A NEVRO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-09-21 2021-03-31 13F/A NEVRO COM Call 11,000 1,534 n/a n/a n/a
2021-05-14 2021-03-31 13F NEVRO COM Call 11,000 1,535 n/a n/a n/a
2023-09-21 2020-12-31 13F/A NEVRO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F NEVRO COM Call 0 0 n/a n/a n/a
2020-11-13 2020-09-30 13F NEVRO COM Call 16,500 -80.59 2,298 -77.37 n/a n/a n/a
2020-11-02 2020-06-30 13F/A NEVRO COM Call 85,000 750.00 10,155 1,467.13 n/a n/a n/a
2020-08-14 2020-06-30 13F NEVRO COM Call 85,000 10,155 n/a n/a n/a
2019-08-14 2019-06-30 13F NEVRO COM Call 10,000 0.00 648 3.68 n/a n/a n/a
2019-05-15 2019-03-31 13F NEVRO COM Call 10,000 625 n/a n/a n/a
2017-02-14 2016-12-31 13F/A NEVRO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F NEVRO COM Call 36,000 200.00 3,758 324.63 n/a n/a n/a
2016-08-12 2016-06-30 13F NEVRO COM Call 12,000 -86.71 885 -82.58 n/a n/a n/a
2016-05-11 2016-03-31 13F NEVRO COM Call 90,300 5,080 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A NEVRO COM Put 150,000 0.00 6,990 6.33 n/a n/a n/a
2022-11-14 2022-09-30 13F NEVRO COM Put 150,000 6,990 n/a n/a n/a
2023-09-21 2022-06-30 13F/A NEVRO COM Put 150,000 0.00 6,574 -39.40 n/a n/a n/a
2022-08-15 2022-06-30 13F NEVRO COM Put 150,000 6,575 n/a n/a n/a
2023-09-21 2022-03-31 13F/A NEVRO COM Put 150,000 -2.02 10,850 -12.59 n/a n/a n/a
2022-05-16 2022-03-31 13F NEVRO COM Put 150,000 10,850 n/a n/a n/a
2023-09-21 2021-12-31 13F/A NEVRO COM Put 153,100 488.85 12,412 310.28 n/a n/a n/a
2022-02-14 2021-12-31 13F NEVRO COM Put 153,100 12,412 n/a n/a n/a
2021-12-17 2021-09-30 13F/A NEVRO COM Put 26,000 3,026 n/a n/a n/a
2023-09-21 2021-09-30 13F/A NEVRO COM Put 26,000 -34.84 3,026 -54.27 n/a n/a n/a
2021-11-15 2021-09-30 13F NEVRO COM Put 26,000 3,026 n/a n/a n/a
2021-08-20 2021-06-30 13F/A NEVRO COM Put 39,900 6,615 n/a n/a n/a
2023-09-21 2021-06-30 13F/A NEVRO COM Put 39,900 84.72 6,615 119.55 n/a n/a n/a
2021-08-16 2021-06-30 13F NEVRO COM Put 3,990,000 6,615 n/a n/a n/a
2023-09-21 2021-03-31 13F/A NEVRO COM Put 21,600 3,013 n/a n/a n/a
2021-05-14 2021-03-31 13F NEVRO COM Put 21,600 3,013 n/a n/a n/a
2023-09-21 2020-12-31 13F/A NEVRO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F NEVRO COM Put 0 0 n/a n/a n/a
2020-11-13 2020-09-30 13F NEVRO COM Put 40,000 -33.33 5,572 -22.27 n/a n/a n/a
2020-11-02 2020-06-30 13F/A NEVRO COM Put 60,000 0.00 7,168 19.49 n/a n/a n/a
2020-08-14 2020-06-30 13F NEVRO COM Put 60,000 7,168 n/a n/a n/a
2020-05-15 2020-03-31 13F NEVRO COM Put 60,000 5,999 n/a n/a n/a
2020-02-13 2019-12-31 13F NEVRO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-13 2019-09-30 13F NEVRO COM Put 31,600 2,772.73 2,717 3,726.76 n/a n/a n/a
2019-08-14 2019-06-30 13F NEVRO COM Put 1,100 71 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.